These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24016252)

  • 1. Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
    Guo Y; Zang C; Li Y; Yuan L; Liu Q; Zhang L; Li S
    Genet Test Mol Biomarkers; 2013 Nov; 17(11):814-20. PubMed ID: 24016252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
    Li W; Wu H; Song C
    Tumour Biol; 2013 Oct; 34(5):2675-81. PubMed ID: 23653379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor β1-509C/T and +869T/C polymorphisms on the risk of upper digestive tract cancer: a meta-analysis based on 10,917 participants.
    Zhang CF; Wang ZW; Hou MX; Li K; Zhou X; Xia YH
    Ann Hum Genet; 2012 Sep; 76(5):363-76. PubMed ID: 22724518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between TGF-β1 rs1982073/rs1800469 polymorphism and lung cancer susceptibility: An updated meta-analysis involving 7698 cases and controls.
    Chen G; Hu C; Lai P; Song Y; Xiu M; Zhang H; Zhang Y; Huang P
    Medicine (Baltimore); 2019 Nov; 98(47):e18028. PubMed ID: 31764821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between TGF-β1 Polymorphisms and Asthma Susceptibility Among the Chinese: A Meta-Analysis.
    Liu Z; Li J; Wang K; Tan Q; Tan W; Guo G
    Genet Test Mol Biomarkers; 2018 Jul; 22(7):433-442. PubMed ID: 29958018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
    Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
    Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis.
    Wang Y; Chu X; Meng X; Zou F
    Tumour Biol; 2014 Feb; 35(2):935-42. PubMed ID: 23982878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population.
    Zhao H; Zou LW; Zheng SS; Geng XP
    Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
    Duan CY; Liu MY; Li SB; Ma KS; Bie P
    Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
    Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
    J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 gene polymorphism in association with diabetic retinopathy susceptibility: a systematic review and meta-analysis.
    Liu L; Jiao J; Wang Y; Wu J; Huang D; Teng W; Chen L
    PLoS One; 2014; 9(4):e94160. PubMed ID: 24710116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between TGF-β1 +869C/T polymorphism and fracture risk: a meta-analysis.
    Zhang ZC; He NB; Zhang T
    Int J Clin Exp Med; 2014; 7(12):5124-9. PubMed ID: 25664014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between transforming growth factor-β1gene-509C/T polymorphism and susceptibility of IgA nephropathy: a meta-analysis.
    Li Z; Li Y; Chen L
    Ren Fail; 2014 Nov; 36(10):1473-80. PubMed ID: 25112155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
    Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
    Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma.
    Song K; Yi J; Shen X; Cai Y
    PLoS One; 2012; 7(11):e48924. PubMed ID: 23185284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS; Im JP; Min BH; Kim HD; Jeong JB; Yoon JH; Kim CY; Kim MS; Kim JY; Jung JH; Kim LH; Park BL; Shin HD
    Exp Mol Med; 2003 Jun; 35(3):196-202. PubMed ID: 12858019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis.
    Lu WQ; Qiu JL; Huang ZL; Liu HY
    Oncotarget; 2016 Dec; 7(51):84695-84704. PubMed ID: 27835897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ +874A/T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Zhou H; Wang L; Li X; Song J; Jiang T; Wu X; Zhou S
    Med Sci Monit; 2015 Mar; 21():689-93. PubMed ID: 25739411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.